$MYO

MYOMO, INC.

CIK:0001369290|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue	$ 11,704,565	$ 9,652,234	$ 21,817,853	$ 19,484,048
Cost of revenue	3,262,017	3,600,061	6,473,698	6,822,246
Gross profit	8,442,548	6,052,173	15,344,155	12,661,802
Operating expenses:
Research and development	1,720,463	2,001,331	3,343,623	3,791,355
Selling, clinical and marketing	5,264,090	5,233,885	10,080,849	9,629,689
General and administrative	3,712,481	3,407,277	7,331,221	7,351,332
Total operating expenses	10,697,034	10,642,493	20,755,693	20,772,376
Loss from operations	(2,254,486)	(4,590,320)	(5,411,538)	(8,110,574)
Other expense (income), net
Interest expense (income), net	535,744	(106,549)	1,040,440	(298,540)
Change in fair value of derivatives liabilities	1,199,726	0	360,662	0
Total Other (income), net	1,735,470	(106,549)	1,401,102	(298,540)
Loss before income taxes	(3,989,956)	(4,483,771)	(6,812,640)	(7,812,034)
Income Tax Expense	31,404	148,201	218,119	284,996
Net loss	$ (4,021,360)	$ (4,631,972)	$ (7,030,759)	$ (8,097,030)
Weighted average number of common shares outstanding:
Basic	42,697,319	41,582,737	42,484,409	41,518,959
Diluted	42,697,319	41,582,737	42,484,409	41,518,959
Net loss per share attributable to common stockholders
Basic	$ (0.09)	$ (0.11)	$ (0.17)	$ (0.2)
Diluted	$ (0.09)	$ (0.11)	$ (0.17)	$ (0.2)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (7,030,759)	$ (8,097,030)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization	676,129	349,240
Stock-based compensation	1,639,913	935,093
Accretion of discount on short-term investments	(73,484)	(23,383)
Credit losses	0	51,643
Amortization of debt discounts	524,479	60,045
Amortization of right-of-use assets	362,699	526,600
Change in fair value of derivatives liabilities	360,662	0
Other non-cash charges	96,612	(91,984)
Changes in operating assets and liabilities:
Accounts receivable	(1,065,154)	(2,975,272)
Inventories	174,977	(1,204,740)
Prepaid expenses and other current assets	(1,032,389)	(615,940)
Other assets	0	(130,801)
Accounts payable and accrued expenses	1,703,910	(531,182)
Operating lease liabilities	(256,321)	140,536
Deferred revenue	(15,642)	25,666
Income taxes payable	(207,400)	(144,392)
Tenant improvement allowance	0	183,726
Net cash used in operating activities	(4,141,768)	(11,542,175)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of equipment	(360,248)	(892,174)
Purchases of software development costs	(211,672)	(1,035,862)
Purchases of short-term investments	0	(1,225,410)
Maturities of short-term investments	2,100,000	500,000
Net cash provided by (used in) investing activities	1,528,080	(2,653,446)
CASH FLOWS FROM FINANCING ACTIVITIES
Deferred debt origination costs	0	(36,506)
Net Proceeds from issuance of debt	0	4,000,000
Taxes paid for net share settlement of restricted stock units	(243,709)	0
Net cash (used in) provided by financing activities	(243,709)	3,963,494
Effect of foreign exchange rate changes on cash	(55,413)	100,186
Net (decrease) increase in cash and cash equivalents	(2,912,810)	(10,131,941)
Cash and cash equivalents, beginning of period	14,707,027	24,747,373
Cash and cash equivalents, end of period	11,794,217	14,615,432
Cash paid during the period for income taxes	92,101	99,163
Cash paid during the period for interest	827,825	70,494
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Right of use assets obtained in exchange for lease obligations	197,370	0
Unrealized gain from mark to market on short-term investments	$ 2,125	$ 268

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 11,219,217	$ 14,132,027
Short-term investments	2,233,141	4,261,782
Accounts receivable, net	4,945,509	4,096,327
Inventories	3,169,372	3,123,089
Prepaid expenses and other current assets	2,958,442	1,943,860
Total Current Assets	24,525,681	27,557,085
Restricted cash	575,000	575,000
Operating lease assets with right of use, net	6,514,020	6,679,349
Equipment, net	1,986,836	2,212,901
Software development costs, net	1,721,532	1,590,864
Other assets	19,185	21,374
Total Assets	35,342,254	38,636,573
Current Liabilities:
Accounts payable and accrued expenses	7,515,613	5,819,767
Current operating and financing lease liability	730,824	494,662
Income taxes payable	586,644	813,260
Deferred revenue	202,580	218,222
Warrant derivative liability	1,127,498	999,418
Current portion long term debt, net of discount of $73,871	446,962	0
Total Current Liabilities	10,610,121	8,345,329
Non-current operating and financing lease liability	7,370,509	7,665,622
Long-term debt, net of discount of $2,437,757	11,532,254	11,222,155
Total Liabilities	29,512,884	27,233,106
Commitments and Contingencies	0	0
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock par value $0.0001 per share, 100,000,000 shares authorized; 39,534,884 and 38,471,383 shares issued as of June 30, 2026 and December 31, 2025, respectively; and 39,534,857 and 38,471,356 shares outstanding at June 30, 2026 and December 31, 2025, respectively	3,953	3,847
Additional paid-in capital	131,326,086	129,929,989
Accumulated other comprehensive income	224,976	164,517
Accumulated deficit	(125,719,181)	(118,688,422)
Treasury stock, 27 shares at cost	(6,464)	(6,464)
Total Stockholders’ Equity	5,829,370	11,403,467
Total Liabilities and Stockholders’ Equity	$ 35,342,254	$ 38,636,573